Preterm DElayed Cord Clamping and Early Skin-to-Skin Contact: PreDECESS
Launched by OSTERGOTLAND COUNTY COUNCIL, SWEDEN · Jan 23, 2023
Trial Information
Current as of July 01, 2025
Recruiting
Keywords
ClinConnect Summary
The PreDECESS trial is studying a new way to care for premature babies born between 30 to 34 weeks of pregnancy. This method includes waiting a little longer to cut the umbilical cord after birth and allowing parents to hold their baby skin-to-skin right away. The goal is to see if these practices help parents bond better with their infants compared to traditional methods. Researchers will also look at any possible health effects on the babies, how they grow, and how well they develop, along with how parents feel and their breastfeeding experience.
To be part of this study, infants must be born between 30 to 34 weeks of pregnancy through vaginal delivery and be admitted to a neonatal ward in Sweden. Parents should be able to read Swedish. However, babies with certain health concerns or conditions, like severe anemia or major birth defects, will not be included. If you participate, you can expect to be part of a supportive environment where your experience as a parent is valued, and your baby's health will be closely monitored.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Infants born in gestational weeks 30+0-34+6 through vaginal delivery and admitted to neonatal ward in Sweden.
- • Parents must be able to read Swedish.
- Exclusion Criteria:
- • Infants with known disease when an expanded blood volume is expected will be excluded as early cord clamping is recommended (severe anemia, cardiac disease etc).
- • Infants with known malformations. Infants with severe or moderate asphyxia (defined as APGAR \< 4 at 5 minutes of age).
- • Infants where the physician in charge find it inappropriate with delayed cord clamping.
- • No time for cord clamping has been registered.
About Ostergotland County Council, Sweden
Östergötland County Council, located in Sweden, is a regional authority dedicated to advancing public health and medical research through the sponsorship of clinical trials. Committed to improving patient outcomes and fostering innovative healthcare solutions, the council collaborates with healthcare professionals, academic institutions, and research organizations. By facilitating rigorous clinical studies, Östergötland County Council aims to contribute to the development of evidence-based practices and enhance the quality of care provided to the community it serves.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Linkoping, , Sweden
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials